You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Bliss GVS Pharma Ltd"

Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015

  • 05/02/2021
  • |
  • bse

Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 25/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Outcome Of Board Meeting Held On Thursday January 21 2021

  • 21/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Shareholding for the Period Ended December 31 2020

  • 16/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 15/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Statement Of Investor Complaints For The Quarter Ended December 2020

  • 15/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 15/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Announcement under Regulation 30 (LODR)-Credit Rating

  • 13/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Board Meeting Intimation for Unaudited Standalone & Consolidated Financial Results Of The Company Fo

  • 13/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 04/01/2021
  • |
  • bse

Bliss GVS Pharma Ltd Closure of Trading Window

  • 29/12/2020
  • |
  • bse

Bliss GVS Pharma Ltd Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

  • 24/12/2020
  • |
  • bse

Bliss GVS Pharma Ltd Intimation About Approval Letters Received From BSE Limited And National Stock Exchange Of India Lim

  • 15/12/2020
  • |
  • bse

Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 13/11/2020
  • |
  • bse

Bliss GVS Pharma Ltd Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 13/11/2020
  • |
  • bse

Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 12/11/2020
  • |
  • bse

Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 12/11/2020
  • |
  • bse

Bliss GVS Pharma Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.

  • 12/11/2020
  • |
  • bse

Bliss GVS Pharma Ltd Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange

  • 05/11/2020
  • |
  • bse

Bliss GVS Pharma Ltd Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligation

  • 29/10/2020
  • |
  • bse
.